United States · Investor

Partner Fund Management (PFM)

Last cheque observed Jun 2020. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries C

Cheques on record
0%of best year0cheques in 12 months, 9 on record
Since the last cheque2325days00hrs00min00sec
Median round$94MRounds led0 of 9Sole investor1 roundsExits1 from the portfolioMostly inUnited States, 100%
Pitch Partner Fund Management (PFM)

Partner Fund Management (PFM) highlights

  1. 01

    9 rounds on record

  2. 02

    Mostly Series B and Series C: 100% of its rounds

  3. 03

    Sole investor in 1 rounds, median $70M

  4. 04

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first9 appearances

  1. 2020

    1 round

  2. Jun
    Shattuck Labs, Inc.Series B · US · Hatteras Venture Partners$118MWith 8 others
  3. 2017

    1 round

  4. Jan
    Neon TherapeuticsSeries B · US · FinSMEs$70MSole investor
  5. 2015

    4 rounds

  6. Jul
    Afferent PharmaceuticalsSeries C · US$55MWith 5 others
  7. Jun
    Outset MedicalSeries C · US$51MWith 5 others
  8. Apr
    Dimension TherapeuticsSeries B · US$65MWith 7 others
  9. Apr
    Voyager TherapeuticsSeries B · US$60MWith 3 others
  10. 2014

    3 rounds

  11. Nov
    Blueprint MedicinesSeries C · US$50MWith 7 others
  12. Oct
    Avidity NanoMedicinesSeries B · US$6.0MWith 4 others
  13. Aug
    Civitas TherapeuticsSeries C · US$55MWith 11 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Civitas TherapeuticsBought by Acorda Therapeutics$525MSept 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Partner Fund Management (PFM). A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Partner Fund Management (PFM)

What does Partner Fund Management (PFM) invest in?

Partner Fund Management (PFM) invests most often at Series B and Series C (100% of the rounds on record).

How active is Partner Fund Management (PFM)?

9 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2020.

What has Partner Fund Management (PFM) invested in recently?

Its most recent investments on record: Shattuck Labs, Inc. (Series B, Jun 2020) and Neon Therapeutics (Series B, Jan 2017).

How big are Partner Fund Management (PFM)'s cheques?

The median round it joins is $94M.

Does Partner Fund Management (PFM) lead rounds?

Rarely, if at all: none of its 9 investments on record names it as the lead.

Where does Partner Fund Management (PFM) invest?

Most of the companies it backs are in the United States (100%).

Is Partner Fund Management (PFM) investing now?

No investments in the last 12 months; the latest was in Jun 2020.

Who does Partner Fund Management (PFM) invest alongside?

Most often RA Capital Management (3 rounds together), Redmile Group (3 rounds together) and Wellington Management (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it